Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]

Saved in:
Bibliographic Details
Published inJournal of affective disorders Vol. 227; p. 198
Main Authors Mischoulon, D., Hylek, L., Yeung, A.S., Clain, A.J., Baer, L., Cusin, C., Ionescu, D.F., Alpert, J.E., Soskin, D.P., Fava, M.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.02.2018
Online AccessGet full text

Cover

More Information
Bibliography:erratum
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:0165-0327
1573-2517
DOI:10.1016/j.jad.2017.10.040